收费全文 | 8076篇 |
免费 | 299篇 |
国内免费 | 47篇 |
耳鼻咽喉 | 203篇 |
儿科学 | 210篇 |
妇产科学 | 441篇 |
基础医学 | 1253篇 |
口腔科学 | 102篇 |
临床医学 | 450篇 |
内科学 | 1904篇 |
皮肤病学 | 188篇 |
神经病学 | 610篇 |
特种医学 | 207篇 |
外国民族医学 | 1篇 |
外科学 | 786篇 |
综合类 | 51篇 |
一般理论 | 1篇 |
预防医学 | 467篇 |
眼科学 | 195篇 |
药学 | 846篇 |
中国医学 | 42篇 |
肿瘤学 | 465篇 |
2023年 | 33篇 |
2022年 | 114篇 |
2021年 | 195篇 |
2020年 | 72篇 |
2019年 | 102篇 |
2018年 | 183篇 |
2017年 | 161篇 |
2016年 | 176篇 |
2015年 | 212篇 |
2014年 | 313篇 |
2013年 | 389篇 |
2012年 | 604篇 |
2011年 | 625篇 |
2010年 | 321篇 |
2009年 | 240篇 |
2008年 | 464篇 |
2007年 | 493篇 |
2006年 | 535篇 |
2005年 | 495篇 |
2004年 | 521篇 |
2003年 | 472篇 |
2002年 | 442篇 |
2001年 | 187篇 |
2000年 | 194篇 |
1999年 | 119篇 |
1998年 | 45篇 |
1997年 | 31篇 |
1996年 | 22篇 |
1995年 | 23篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 24篇 |
1991年 | 31篇 |
1990年 | 28篇 |
1989年 | 20篇 |
1988年 | 34篇 |
1987年 | 30篇 |
1986年 | 29篇 |
1985年 | 33篇 |
1984年 | 24篇 |
1983年 | 23篇 |
1982年 | 24篇 |
1981年 | 16篇 |
1979年 | 29篇 |
1978年 | 19篇 |
1977年 | 24篇 |
1975年 | 38篇 |
1974年 | 19篇 |
1973年 | 19篇 |
1971年 | 22篇 |
Background
Metabolic syndrome has clinical implications for chronic liver disease, but the relationship between chronic hepatitis B and metabolic syndrome remains unclear. The aim of this study was to determine whether hepatitis B surface antigen (HBsAg) positivity is associated with metabolic syndrome.Methods
Data were obtained from the Third Korean National Health and Nutrition Examination Survey (KNHANES). Participant sera were tested for HBsAg. Metabolic syndrome was defined according to the modified National Cholesterol Education Program Adult Treatment Panel III guidelines for Koreans.Results
Of the 5108 participants, 209 (4.1%) tested positive for HBsAg, and 1364 (26.7%) were diagnosed with metabolic syndrome. The prevalence of metabolic syndrome was 23.4% in HBsAg-positive men, 31.5% in HBsAg-negative men, 18.6% in HBsAg-positive women, and 23.7% in HBsAg-negative women. After adjusting for multiple factors, male participants who tested positive for serum HBsAg had an odds ratio of 0.612 (95% confidence interval [CI] 0.375–0.998) for metabolic syndrome and an odds ratio of 0.631 (95% CI 0.404–0.986) for elevated triglycerides. Women who tested positive for serum HBsAg had an odds ratio of 0.343 (95% CI 0.170–0.693) for elevated triglycerides.Conclusions
Positive results for serum HBsAg are inversely associated with metabolic syndrome in men and with elevated triglycerides in men and women. This suggests that elevated triglycerides may contribute to the inverse association between HBsAg and metabolic syndrome.Key words: chronic hepatitis B, metabolic syndrome, survey, triglycerides 相似文献The aim of the study was to assess the effectiveness of Superb Micro-vascular Imaging (SMI) as an alternative to Contrast-Enhanced Ultrasound (CEUS) and Computed Tomography Angiography (CTA) for endoleak detection and classification in patients followed up after endovascular abdominal aortic aneurysm repair (EVAR).
Materials and methodsFrom May 2015 to January 2017, 30 patients underwent post-EVAR follow-up with Color Doppler Ultrasound (CDUS), CEUS, SMI, and CTA examinations. Aneurysmal sac diameter and graft patency were evaluated; endoleaks were identified and classified. Sensitivity, specificity, and accuracy values were calculated for each of the four diagnostic methods of endoleak detection. A percentage of agreement and Cohen’s Kappa coefficient were calculated for comparison of methods in terms of endoleak identification.
ResultsCTA revealed fifteen endoleaks (50%): three type Ia, nine type II, and three type III. The sensitivity of CDUS, CEUS, and SMI relative to CTA was 27%, 100%, and 100%, respectively. Specificity was 93%, 93%, and 93%, respectively. Accuracy was 60%, 97%, and 97%, respectively. There were no differences between SMI and CEUS in terms of sensitivity, specificity, or accuracy (100%, 93%, and 97%). We do not observe statistically significant differences between CTA, CEUS, and SMI concerning endoleak identification ability. The weakest method in endoleak identification was CDUS.
ConclusionsThe analysis showed that SMI is effective, repeatable, and comparable with the CEUS modality in identification endoleaks after EVAR; it may be considered as a potential tool to monitor patients after EVAR implantation, especially those with renal insufficiency or with an allergy to any contrast media.
相似文献Preclinical Research |